Published January, 2015
By Sybille Mazurek and Maria Shoshan
Publisher: Springer (Springer Verlag GmbH)
Rating:
Availability: Available

The four sections of this book cover cell and molecular biology of tumor metabolism, metabolites, tumor microenvironment, diagnostics and epigenetics. Written by international experts, it provides a thorough insight into and understanding of tumor cell metabolism and its role in tumor biology.

---

Published January, 2015
By Diane Palmieri
Publisher: Springer
Series: Cancer Metastasis - Biology and Treatment
Rating:
Availability: Available

Here is a thorough survey of the biology and treatment of CNS metastasis, including natural history, risk factors, molecular biology, the blood-brain barrier, imaging, quality of life, surgery, chemotherapy, radiation and the future of targeted therapies.

---

Published January, 2015
By James A. Radosevich
Publisher: Springer
Rating:
Availability: Available

"HPV and Cancer" is a concise read that covers all aspects of the Human Papilloma Virus as it relates to human cancers. We then look at the dynamic trends of this infectious agent in the human population, how it interacts with human cells, and the role it plays with other organisms to produce both benign and malignant tumors.

---

Published January, 2015
By Stefan Offermanns, Susan G Amara, Bernd Nilius, Ole H. Petersen, Reinhard Jahn, Thomas Gudermann and Roland Lill
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Reviews of Physiology, Biochemistry and Pharmacology
Rating:
Availability: Available

Induced pluripotent stem cells in cardiovascular research.- TRPs in the brain.- The channel physiology of the skin.

---

Published January, 2015
By Anton G. Kutikhin, Arseniy E. Yuzhalin and Elena B. Brusina
Publisher: Springer
Rating:
Availability: Available

This book describes and analyzes connections between unconventional carcinogenic infectious agents and cancer. It features helpful tables that systematize the key information on the field and a list of all infectious agents suspected in cancer causation.

---

Published January, 2015
By Valerie Quesniaux, Bernhard Ryffel and Franco Di Padova
Publisher: Springer (Springer Basel)
Series: Progress in Inflammation Research
Rating: 1.00
Availability: Available

The knowledge of Th17 cells and other cell populations which secrete IL-17A, and/or IL-22 has expanded tremendously since the publication of the first edition "Th17 Cells: Role in Inflammation and Autoimmune Disease" in 2008.

---

Published January, 2015
By Jiade J. Lu, Nancy Y. Lee and Nadeem Riaz
Publisher: Springer (Springer International Publishing AG)
Series: Medical Radiology
Rating:
Availability: Available

This textbook is designed to help the busy radiation oncologist to accurately and confidently delineate tumor volumes for conformal radiation therapy (including IMRT).

---

Published January, 2015
By Kenneth C. Anderson and Nikhil C. Munshi
Publisher: Springer (Springer-Verlag New York Inc.)
Rating: 1.00
Availability: Available

This new paradigm for overcoming drug resistance and improving patient outcome in MM has great promise not only to change the natural history of MM, but also to serve as a model for targeted therapeutics directed to improve outcome of patients with MM.

---

Published January, 2015
By Moulay A. Alaoui-Jamali, Lawrence C. Panasci, Raquel Aloyz, Lawrence Panasci and Moulay Alaoui-Jamali
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

A comprehensive review of the recent developments in DNA repair research that have potential for translational applications.

---

Published January, 2015
By Gail Lewis Phillips
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

---